Related Experiment Video
Updated: Jul 11, 2025

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
Published on: July 3, 2015
Pharmacodynamic Age Structured Population Model For Cell Trafficking
Wojciech Krzyzanski1, Robert Bauer2
1Department of Pharmaceutical Sciences, University at Buffalo, 370 Pharmacy Building, Buffalo, NY 14214, USA.
This study developed an age-structured cell population model to quantify drug effects on immune cell trafficking. The model successfully explained the rebound in blood cell counts after corticosteroid administration, validating its use in pharmacometric analysis.
Area of Science:
- Pharmacometrics
- Immunology
- Mathematical Modeling
Background:
- Cell trafficking is crucial for immune system function, involving immune cell movement between blood and tissues.
- Corticosteroids are known to suppress immune cell trafficking, impacting immune responses.
- Age-structured models quantify immune cell transit times in blood and extravascular tissues.
Purpose of the Study:
- To develop an age-structured cell population model for quantifying drug effects on cell trafficking.
- To implement this model in pharmacometric software for parameter estimation and simulations.
- To investigate the impact of drug-induced changes in cell trafficking on immune cell dynamics.
Main Methods:
- Adopted the McKendrick age-structured population model for blood and extravascular cell populations.
- Modeled age-dependent cell recirculation using a Weibull function.
- Incorporated drug effects on cell trafficking via an Emax function of plasma concentration, implemented in NONMEM.
Main Results:
- The age structure was essential for explaining the rebound in blood cell counts post-drug administration (ν >1).
- Model parameter estimates included ν=3.02, β=0.00863 1/h, and IC50=7.47 ng/mL.
- Calculated baseline mean transit times for basophils were 7.2 h (blood) and 104.9 h (extravascular tissues).
Conclusions:
- An age-structured population model was developed to describe drug-modulated cell trafficking between blood and tissues.
- The model successfully accounted for inhibitory drug effects on cell recirculation.
- The model's ability to explain rebound phenomena was validated using basophil responses to dexamethasone treatment.
More Related Videos
08:17Probing Structural and Dynamic Properties of Trafficking Subcellular Nanostructures by Spatiotemporal Fluctuation Spectroscopy
Published on: August 16, 2021
10:24Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.